Comments regarding ‘Outcome Following Carotid Endarterectomy: Lessons Learned From a Large International Vascular Registry’  by Beard, J.
Eur J Vasc Endovasc Surg (2011) 41, 741INVITED COMMENTARY
Comments regarding ‘Outcome Following Carotid
Endarterectomy: Lessons Learned From a Large
International Vascular Registry’J. Beard*Sheffield Vascular Institute, Sheffield, UK
Submitted 9 March 2011; accepted 9 March 2011The authors have analysed an impressive dataset from the
Vascunet Registry to ask some simple questions about
the relationship between outcomes and age, sex, type of
anaesthetic and type of endarterectomy. Their results
agree with the previous randomised clinical trials (RCTs),
i.e. the type of anaesthesia did not make a difference;
patching reduced the stroke rate; and both elderly women
and those with a contralateral occlusion were at a higher
risk of stroke. This information, together with the trial
data, means that we can now regard these facts as Level 1
evidence. No further studies of these questions are needed!
It was disappointing that the authors did not collect data
on the proportion of patients receiving best medical therapy
(BMT), i.e. smoking cessation, antiplatelet therapy, statins,
ace-inhibitors and beta-blockers. There is increasing evi-
dence that modern BMT dramatically reduces the risk of
stroke and probably also reduces the risk of any intervention.
The question is by how much, and whether BMT is now so
good that there is no longer much justification for interven-
tion. There is only one current trial (SPACE2) which includes
a BMTarm. This is probably because commercial sponsors are
reluctant to fund a trial which might show that intervention
is not cost-effective. The best evidence is therefore likely to
come from registries which ask these questions, and which
also includes patients who have BMT alone.
The other current controversies concern the benefit of
intervention for asymptomatic disease, and the relationshipDOI of original article: 10.1016/j.ejvs.2011.02.028.
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doi:10.1016/j.ejvs.2011.03.001with the speedof interventionafter theonsetof symptoms, as
other registries have shown worse outcomes than those
reported from RCTs. A significant relationship between volu-
me and outcomes has been demonstrated for other inter-
ventions, such as AAA repair volumes. It is difficult to address
this question in RCTs, because centres and proceduralists
tend to be highly selected. These important data are there-
fore likely to come only from large registries. Information on
regional variations regarding all these factorswould also be of
interest as it might highlight areas of good or poor practise.
The biggest challenge for any voluntary registry is missing
patients, missing data and incorrect data. The best way to
avoid the problem of missing data is to ensure that national
registries are integrated with hospital activity and reim-
bursement systems e no data Z no payment! The risk of
missing patients can also be reduced by expanding the
registry to include all patients with the disease. This
increases theworkload but gives valuable data on the impact
of the intervention on the burden of disease. Such registries
are of great interest to health economists and health care
providers. There is suspicion that adverse outcomes
following intervention are sometimes ‘overlooked’ by pro-
ceduralists. This can be avoided if the outcome data is
collected by an independent datamonitor. This best practice
should be recommended and recorded by registries. Stan-
dards are also required for independent validation of data.
The Vascunet Registry has made an important contribu-
tion to our knowledge of carotid intervention. The Registry
may be able to answer many important questions in the
future, but only if the right questions are asked and the
data can be shown to be complete and accurate.d by Elsevier Ltd. All rights reserved.
